Arkolith/Insider Trading/ADMA/Form 4

Grossman Adam S

President and CEO, DirectorADMA BIOLOGICS, INC. (ADMA) · full profile →Form 4 · filed Dec 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$416K
Net Open-Market Flow
-$416K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Sell(S)6K$19.79$119K2.0M
Dec 15, 2025Option exercise(M)15K$5.40$81K2.0M
Dec 15, 2025Sell(S)15K$19.79$297K2.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)15K—$0721K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-045737) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML